Welcome to our dedicated page for Zentek Ltd. SEC filings (Ticker: ZTEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zentek Ltd. filings document current-report disclosures for a Canadian issuer commercializing graphene-enabled and advanced material technologies. The company’s Form 6-K reports include exhibits on ZenGUARD™ enhanced air filters, Health Canada regulatory classification, commercialization activity and intellectual-property-based product platforms.
Regulatory filings also document Albany Graphite Project work through technical, environmental, social and economic-study disclosures, including high-purity graphite market positioning and critical-minerals analysis. Other filing subjects include Triera Biosciences contracts and aptamer-platform development, material agreements, shareholder voting matters, capital-structure disclosure, governance matters and operating and financial results.
Zentek Ltd. filed a Form 6-K as a foreign private issuer for August 2025. The report is signed by the chief financial officer, Wendy Ford, on behalf of the company.
The filing includes a press release dated August 27, 2025, stating that Zentek received a Nasdaq notification regarding a minimum bid price deficiency.
Zentek Ltd. furnished a Form 6-K to inform investors that it has distributed a management information circular and related materials to shareholders of record as of August 8, 2025 for its 2025 Annual and Special Meeting of Shareholders, scheduled for September 25, 2025. The filing also states that the notice of meeting and management information circular dated August 15, 2025 are incorporated by reference into Zentek’s existing Form F-3 shelf registration statement, becoming part of that registration from the date this report is furnished.
Zentek Ltd. filed a Form 6-K as a foreign private issuer for August 2025. The filing mainly makes several interim reporting documents part of its existing Form F-3 shelf registration, so they can be used in connection with potential future securities offerings.
The submission lists unaudited condensed interim consolidated financial statements for the three months ended June 30, 2025 and 2024, a related management’s discussion and analysis for the same period, and CEO and CFO interim filing certifications dated August 14, 2025.